‘Point-of-care manufacture’ of advanced therapies is already being used in hospitals in the UK, Spain, Switzerland and the US.
- Associate Professor in Regulation, Innovation and Public Policy, UCL
Contact Irina for
- General
- Media request
- Speaking request
- Consulting / Advising
- Research collaboration
- Research supervision
